| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/01/1986 | CA1202587A1 Semi-synthetic preparation of human insulin |
| 04/01/1986 | CA1202585A1 Process for preparing substance having carcinostatic and immunostimulating activity |
| 04/01/1986 | CA1202581A1 Adaptor molecules for dna and their application to synthesis of gene-derived products |
| 04/01/1986 | CA1202566A1 Separation of plasma proteins from cell culture systems |
| 03/27/1986 | WO1986001834A1 Retroviral polypeptides associated with human cellular transformation |
| 03/27/1986 | WO1986001828A1 Cyclic double-stranded dna, process for its preparation, microorganism containing said cyclic double-stranded dna, and process for preparing protein containing antigen determinant site of poliovirus capside protein vp1 using the same |
| 03/27/1986 | WO1986001827A1 Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav) |
| 03/27/1986 | WO1986001808A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001807A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001806A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001805A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001804A1 Monoclonal antibodies and their use |
| 03/27/1986 | WO1986001803A1 Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them |
| 03/27/1986 | WO1986001802A1 Antigens of plasmodium falciparum |
| 03/27/1986 | WO1986001723A1 Method of rectification of human leukocytic interferon |
| 03/27/1986 | WO1986001722A1 Method of obtaining human leukocytic interferon |
| 03/27/1986 | WO1986001721A1 Cross-reactive and protective epitopes of circumsporozoite proteins |
| 03/27/1986 | WO1986001718A1 METHOD FOR OBTAINING THE COMPLEX FVIII/vWF OF THERAPEUTIC USE AND PRODUCTS RESULTING THEREFROM |
| 03/27/1986 | WO1986001209A3 New p-phenylenediamine peptides and reactance containing them for the determination of proteases of the blood coagulation system |
| 03/26/1986 | EP0175613A2 Immunogenic hav peptides |
| 03/26/1986 | EP0175577A2 Microchemiluminescent assay system |
| 03/26/1986 | EP0175506A2 GnRH antagonists |
| 03/26/1986 | EP0175360A2 Peptide antibodies and their use in detecting oncogene products |
| 03/26/1986 | EP0175323A2 Biologically active peptides, processes for preparing them and pharmaceutical compositions |
| 03/26/1986 | EP0175310A1 A substantially pure rheumatoid arthritis specific protein and an antibody against the same |
| 03/26/1986 | EP0175289A2 Treatment of diarrhoea with alpha-interferons |
| 03/26/1986 | EP0175283A1 Recombinant dna and use thereof |
| 03/26/1986 | EP0175269A2 Immunogen conjugates and the use thereof in a dihydropyridine assay |
| 03/26/1986 | EP0175261A2 Hybrid particle immunogens |
| 03/26/1986 | EP0175100A2 Process for preparing antibiotic L17046, a teicoplanin derivative |
| 03/26/1986 | EP0174993A1 Bone protein purification process |
| 03/25/1986 | US4578335 Interleukin 2 receptor |
| 03/25/1986 | US4578218 Purification of factor VIII with insoluble matrix having free sulfate groups covalently bound thereto |
| 03/25/1986 | US4578217 Synthetic antigenic peptide derived from hepatitis B surface antigen |
| 03/25/1986 | US4578079 Tetrapeptide |
| 03/25/1986 | CA1202261A1 A47934 antibiotic and its production |
| 03/25/1986 | CA1202258A1 Expression vector carrying a gene coding for a phosphate-binding protein, a method for preparing the same and a method for producing a polypeptide using the same |
| 03/25/1986 | CA1202256A2 Microbial expression of quasi-synthetic genes |
| 03/19/1986 | EP0174874A2 Hybrid cell line producing monoclonal antibody cytolytic to trichomonas vaginalis |
| 03/19/1986 | EP0174810A2 Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein DNA |
| 03/19/1986 | EP0174805A1 Immunodiagnostic methods |
| 03/19/1986 | EP0174785A1 A positive retroregulatory element, plasmid and cells comprising said element and their production, a method of enhancing gene expression using said element and a method of enhancing RNA half life using said element |
| 03/19/1986 | EP0174759A1 Multispecific immunogenic proteins |
| 03/19/1986 | EP0174669A2 Process for the production of a hybrid DNA containing the complementary hepatitis A virus genome, this hybrid DNA and plasmid vector containing it, virus-specific proteins expressed by this hybrid DNA, vaccines containing and produced from these proteins |
| 03/19/1986 | EP0174608A1 Beta-actin gene and regulatory elements, preparation and use |
| 03/19/1986 | EP0174585A2 Promoters and the use thereof in the expression of unfused procaryotic or eucaryotic proteins in yeast |
| 03/19/1986 | EP0174571A2 Derivatives of amino acids, process for their preparation and pharmaceutical compositions |
| 03/19/1986 | EP0174444A2 Hepatitis surface antigen particle vaccine |
| 03/18/1986 | US4576745 Method for the fluorimetric determination of endotoxins, new peptides carrying a fluorophorous substance usable in said method and method for its preparation |
| 03/18/1986 | EP0162078A4 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein. |
| 03/13/1986 | WO1986001540A1 Modified insulin precursors products and processes |
| 03/13/1986 | WO1986001539A1 Method of producing monoclonal anti-idiotypic antibodies |
| 03/13/1986 | WO1986001536A1 Bacillus thuringiensis crystal protein gene toxin segment |
| 03/13/1986 | WO1986001535A1 Molecular clones of the genome of htlv-iii |
| 03/13/1986 | WO1986001534A1 Recombinant dna and its use |
| 03/13/1986 | WO1986001533A1 Production of chimeric antibodies |
| 03/13/1986 | WO1986001532A1 Polypeptide and polypeptide composition |
| 03/13/1986 | WO1986001531A1 Detachment of anchorage-dependent cells from microcarriers |
| 03/13/1986 | WO1986001530A1 A process for proliferation of wholly or partially differentiated beta-cellls |
| 03/13/1986 | WO1986001517A1 Herpes virus specific immunological materials and methods |
| 03/13/1986 | WO1986001516A1 Cyclic polypeptides having mu-receptor specificity |
| 03/13/1986 | WO1986001515A1 Expression of human connective tissue activator and related peptides |
| 03/13/1986 | WO1986001410A1 Antibody-metal ion complexes |
| 03/13/1986 | WO1986001409A1 Acid-cleavable compound |
| 03/13/1986 | WO1986001408A1 Antiviral peptides |
| 03/13/1986 | WO1986001407A1 Monoclonal antibodies against metal chelates |
| 03/12/1986 | EP0174228A1 Process for diagnosing human Papilloma virus infections, monoclonal antibodies specific for a type of human Papilloma virus, and hybridomalines secreting them |
| 03/12/1986 | EP0174204A2 Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof |
| 03/12/1986 | EP0174162A2 Pharmaceutically active dipeptide derivatives |
| 03/12/1986 | EP0174143A1 Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and DNA and transfected hosts therefor |
| 03/12/1986 | EP0173997A1 Feline leukemia virus protein vaccines and their preparation |
| 03/12/1986 | EP0173973A2 Method for the determination of thyroid-stimulating hormone |
| 03/12/1986 | EP0173937A2 Method of increasing the permeability of yeast cells |
| 03/12/1986 | EP0173935A1 Hybrid lymphoblastoid-leukocyte human interferons |
| 03/12/1986 | EP0173924A2 Mechanical process for dislodging bacterial cells for the isolation of peptides prepared by recombinant techniques |
| 03/12/1986 | EP0173887A1 Novel interferon alphas |
| 03/12/1986 | EP0173712A1 Immunization by immunogenic implant |
| 03/11/1986 | US4575495 Vaccine |
| 03/11/1986 | US4575489 Streptomyces albulus subsp. ochragerus subsp. nov. culture for making peptide |
| 03/11/1986 | CA1201710A1 Analgesic compounds |
| 03/05/1986 | EP0173668A1 Recombinant saccharomyces |
| 03/05/1986 | EP0173629A1 Antibody-metal ion complexes |
| 03/05/1986 | EP0173619A1 Method for the preparation of a strain, particularly from yeast, transformed by an expression vector, that can be propagated in a complete medium, without selection pressure, and strain thus obtained |
| 03/05/1986 | EP0173557A2 Peptides |
| 03/05/1986 | EP0173552A1 Recombinant DNA compounds and the expression of polypeptides such as tPA |
| 03/05/1986 | EP0173529A1 Molecular clones of the genome of HTLV-III |
| 03/05/1986 | EP0173527A2 Insulin-selective somatostatin analogs |
| 03/05/1986 | EP0173500A1 Methods of concentrating ligands and active membranes used therefor |
| 03/05/1986 | EP0173494A2 Chimeric receptors by DNA splicing and expression |
| 03/05/1986 | EP0173481A2 Peptides |
| 03/05/1986 | EP0173384A2 Polypeptide relating to alpha-hANP |
| 03/05/1986 | EP0173378A2 Process for preparing a polypeptide by culturing a transformed microorganism, a transformed microorganism suitable therefor and DNA sequences suitable for preparing such microorganism |
| 03/05/1986 | EP0173280A1 Plasmids containing lambda Pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, hosts containing the plasmids and related methods |
| 03/05/1986 | EP0173268A2 A method for the preparation of a herpes simplex virus subunit vaccine |
| 03/05/1986 | EP0173254A1 DNA sequences of the EBV genome, recombinant DNA molecules, processes for producing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens |
| 03/05/1986 | EP0173242A2 Process for the production of a pasteurized isoagglutinin-free Faktor VIII preparation from a cryoprecipitate. |
| 03/05/1986 | EP0173215A2 Method for recovering purified growth hormones from genetically engineered microorganisms |
| 03/05/1986 | EP0173149A1 Synthetic regulation region |
| 03/05/1986 | EP0173092A2 Anti viral composition |
| 03/04/1986 | CA1201396A1 Process for the preparation of permanent animal and human cell lines and their use |